Johnson & Johnson (JNJ) 104.05 $JNJ
Final Glance: Medical Devices companies
AP - Mon Sep 08, 5:38PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Final Glance: Pharmaceuticals companies
AP - Mon Sep 08, 5:38PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Glaxo Announces EU Nod for Single-Pill HIV Drug Triumeq - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 08, 4:25PM CDT
ViiV Healthcare's Triumeq approved for the treatment of HIV-1 infection in patients above 12 years and weighing at least 40kg.
Transvaginal Mesh Lawsuit News: Pennsylvania Court Denies Manufacturers' Bid to Have Mesh Suits Dismissed, The Rottenstein Law Group LLP Reports
PRWeb - Mon Sep 08, 2:03PM CDT
The preliminary objections of defendant vaginal mesh manufacturers Boston Scientific Corp., Ethicon Inc., Johnson & Johnson, C.R. Bard Inc., and American Medical Systems Inc. were overruled without prejudice by the Court of Common Pleas, First Judicial District of Pennsylvania (Philadelphia) on September 2, according to an order of the court filed in In re: Pelvic Mesh Litigation (case no. 140200829). The mesh manufacturers may still seek summary judgment on a case-by-case basis.
Labor Market Woes Lead Dividend Stocks Higher as Interest Rates Lay Low
at The Street - Mon Sep 08, 1:15PM CDT
Latest weak payrolls figure signals U.S. rates may remain low, keeping demand for dividend yielding stocks strong.
Ebola Outbreak Strikes Africa: How We're Fighting Back
Brian Orelli, The Motley Fool - Motley Fool - Mon Sep 08, 12:37PM CDT
This week, the World Health Organization announced that the Ebola outbreak in West Africa has killed more than 1,900 people. This is the largest Ebola outbreak in history, with more people dying in this outbreak than all the other outbreaks since the...
Midday Glance: Medical Devices companies
AP - Mon Sep 08, 1:11PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Midday Glance: Pharmaceuticals companies
AP - Mon Sep 08, 1:11PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
3 Reasons Medtronic Inc. Stock Could Rise
Leo Sun, The Motley Fool - Motley Fool - Mon Sep 08, 12:01PM CDT
Last month, Medtronic 's first-quarter earnings topped consensus estimates on the top and bottom lines, as revenue rose 5% year over year to $4.27 billion and non-GAAP diluted earnings climbed 6% to $0.93 per share. Medtronic posted positive...
Early Glance: Pharmaceuticals companies
AP - Mon Sep 08, 9:34AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Early Glance: Medical Devices companies
AP - Mon Sep 08, 9:34AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
The Zacks Analyst Blog Highlights: Intel, Advanced Micro Devices, Johnson & Johnson, Bayer and McDonald's
PR Newswire - Mon Sep 08, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Intel Corporation (Nasdaq:INTC-Free Report), Advanced Micro Devices (NYSE:AMD-Free Report), Johnson & Johnson (NYSE:JNJ-Free Report), Bayer (OTC:BAYRY-Free Report) and McDonald's Corp. (NYSE:MCD-Free Report).
How 5 Summer Industries Stay Warm in Winter
at The Street - Mon Sep 08, 7:30AM CDT
Amusement parks and sunscreen manufacturers are among the warm-weather businesses that figured out how to thaw off-peak sales.
Janssen Inc. and Johnson & Johnson Innovation establish research collaboration with the University of Toronto
CNW Group - Mon Sep 08, 7:00AM CDT
Neuroscience Catalyst to Focus on Mood Disorders and Alzheimer's Disease
CollPlant Names Dr. Nadav Orr Vice President Research and Development
PR Newswire - Mon Sep 08, 5:26AM CDT
CollPlant (TASE: CLPT), a developer and manufacturer of human collagen-based medical products has announced that Dr. Nadav Orr has been appointed Vice President of Research & Development, effective September 7, 2014.
How to Prepare for a Stock Market Crash
Matthew Frankel, The Motley Fool - Motley Fool - Sun Sep 07, 1:40PM CDT
We never want to see the stock market crash, but it's always a good idea to prepare for the worst, especially when the market just keeps going up, up, and up. At some point we'll at least see a correction, but some experts think the inevitable rise...
7 States Where Diabetes Prevalence Is the Highest
Sean Williams, The Motley Fool - Motley Fool - Sat Sep 06, 12:14PM CDT
Diabetes: It's one of the most widespread chronic diseases in the United States, yet is also one of the most ignored and underdiagnosed. According to the latest statistics from the Centers for Disease Control and Prevention in its National...
The Surprising Over-the-Counter Pain Reliever Consumers Are Least Loyal To
Sean Williams, The Motley Fool - Motley Fool - Sat Sep 06, 8:23AM CDT
Source: Anthony Easton via Flickr . If you're anything like me, walking down the first-aid aisle in the grocery store or drugstore creates a deer in the headlights look nearly every time. The amount of over-the-counter therapeutics that consumers...
Stryker Grows via Acquisitions but M&A Deals Pose Risk - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 4:40PM CDT
For 2014, Stryker (SYK) expects to report adjusted earnings of $4.75 to $4.80 per share for full year 2014, indicating a 10.5 to 11.6% rise from 2013.
Jury Decides for Wexler Wallace LLP Client Against J&J Subsidiary: $3.27 Million
PR Newswire - Fri Sep 05, 4:25PM CDT
After a two-week trial in Huskey v. Ethicon pending in the United States District Court for the Southern District of West Virginia, an eight-member jury returned a verdict just before noon today for Wexler Wallace LLP client Jo Huskey, who was also represented by Jeffrey M. Kuntz of Wagstaff & Cartmell LLP and Fidelma L. Fitzpatrick of Motley Rice LLC. The jury found that Huskey had proven, by a preponderance of the evidence, her claims for defective design, failure to warn, and negligence related to the implantation of transvaginal tape manufactured by Ethicon, Inc., a subsidiary of Johnson & Johnson.
Final Glance: Medical Devices companies
AP - Mon Sep 08, 5:38PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Final Glance: Pharmaceuticals companies
AP - Mon Sep 08, 5:38PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Glaxo Announces EU Nod for Single-Pill HIV Drug Triumeq - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 08, 4:25PM CDT
ViiV Healthcare's Triumeq approved for the treatment of HIV-1 infection in patients above 12 years and weighing at least 40kg.
Transvaginal Mesh Lawsuit News: Pennsylvania Court Denies Manufacturers' Bid to Have Mesh Suits Dismissed, The Rottenstein Law Group LLP Reports
PRWeb - Mon Sep 08, 2:03PM CDT
The preliminary objections of defendant vaginal mesh manufacturers Boston Scientific Corp., Ethicon Inc., Johnson & Johnson, C.R. Bard Inc., and American Medical Systems Inc. were overruled without prejudice by the Court of Common Pleas, First Judicial District of Pennsylvania (Philadelphia) on September 2, according to an order of the court filed in In re: Pelvic Mesh Litigation (case no. 140200829). The mesh manufacturers may still seek summary judgment on a case-by-case basis.
Labor Market Woes Lead Dividend Stocks Higher as Interest Rates Lay Low
at The Street - Mon Sep 08, 1:15PM CDT
Latest weak payrolls figure signals U.S. rates may remain low, keeping demand for dividend yielding stocks strong.
Ebola Outbreak Strikes Africa: How We're Fighting Back
Brian Orelli, The Motley Fool - Motley Fool - Mon Sep 08, 12:37PM CDT
This week, the World Health Organization announced that the Ebola outbreak in West Africa has killed more than 1,900 people. This is the largest Ebola outbreak in history, with more people dying in this outbreak than all the other outbreaks since the...
Midday Glance: Medical Devices companies
AP - Mon Sep 08, 1:11PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Midday Glance: Pharmaceuticals companies
AP - Mon Sep 08, 1:11PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
3 Reasons Medtronic Inc. Stock Could Rise
Leo Sun, The Motley Fool - Motley Fool - Mon Sep 08, 12:01PM CDT
Last month, Medtronic 's first-quarter earnings topped consensus estimates on the top and bottom lines, as revenue rose 5% year over year to $4.27 billion and non-GAAP diluted earnings climbed 6% to $0.93 per share. Medtronic posted positive...
Early Glance: Pharmaceuticals companies
AP - Mon Sep 08, 9:34AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Early Glance: Medical Devices companies
AP - Mon Sep 08, 9:34AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
The Zacks Analyst Blog Highlights: Intel, Advanced Micro Devices, Johnson & Johnson, Bayer and McDonald's
PR Newswire - Mon Sep 08, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Intel Corporation (Nasdaq:INTC-Free Report), Advanced Micro Devices (NYSE:AMD-Free Report), Johnson & Johnson (NYSE:JNJ-Free Report), Bayer (OTC:BAYRY-Free Report) and McDonald's Corp. (NYSE:MCD-Free Report).
How 5 Summer Industries Stay Warm in Winter
at The Street - Mon Sep 08, 7:30AM CDT
Amusement parks and sunscreen manufacturers are among the warm-weather businesses that figured out how to thaw off-peak sales.
Janssen Inc. and Johnson & Johnson Innovation establish research collaboration with the University of Toronto
CNW Group - Mon Sep 08, 7:00AM CDT
Neuroscience Catalyst to Focus on Mood Disorders and Alzheimer's Disease
CollPlant Names Dr. Nadav Orr Vice President Research and Development
PR Newswire - Mon Sep 08, 5:26AM CDT
CollPlant (TASE: CLPT), a developer and manufacturer of human collagen-based medical products has announced that Dr. Nadav Orr has been appointed Vice President of Research & Development, effective September 7, 2014.
How to Prepare for a Stock Market Crash
Matthew Frankel, The Motley Fool - Motley Fool - Sun Sep 07, 1:40PM CDT
We never want to see the stock market crash, but it's always a good idea to prepare for the worst, especially when the market just keeps going up, up, and up. At some point we'll at least see a correction, but some experts think the inevitable rise...
7 States Where Diabetes Prevalence Is the Highest
Sean Williams, The Motley Fool - Motley Fool - Sat Sep 06, 12:14PM CDT
Diabetes: It's one of the most widespread chronic diseases in the United States, yet is also one of the most ignored and underdiagnosed. According to the latest statistics from the Centers for Disease Control and Prevention in its National...
The Surprising Over-the-Counter Pain Reliever Consumers Are Least Loyal To
Sean Williams, The Motley Fool - Motley Fool - Sat Sep 06, 8:23AM CDT
Source: Anthony Easton via Flickr . If you're anything like me, walking down the first-aid aisle in the grocery store or drugstore creates a deer in the headlights look nearly every time. The amount of over-the-counter therapeutics that consumers...
Stryker Grows via Acquisitions but M&A Deals Pose Risk - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 4:40PM CDT
For 2014, Stryker (SYK) expects to report adjusted earnings of $4.75 to $4.80 per share for full year 2014, indicating a 10.5 to 11.6% rise from 2013.
Jury Decides for Wexler Wallace LLP Client Against J&J Subsidiary: $3.27 Million
PR Newswire - Fri Sep 05, 4:25PM CDT
After a two-week trial in Huskey v. Ethicon pending in the United States District Court for the Southern District of West Virginia, an eight-member jury returned a verdict just before noon today for Wexler Wallace LLP client Jo Huskey, who was also represented by Jeffrey M. Kuntz of Wagstaff & Cartmell LLP and Fidelma L. Fitzpatrick of Motley Rice LLC. The jury found that Huskey had proven, by a preponderance of the evidence, her claims for defective design, failure to warn, and negligence related to the implantation of transvaginal tape manufactured by Ethicon, Inc., a subsidiary of Johnson & Johnson.
